These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 7915526

  • 1. The gene causing multiple endocrine neoplasia type 2 (MEN 2).
    Ponder BA.
    Ann Med; 1994 Jun; 26(3):199-203. PubMed ID: 7915526
    [Abstract] [Full Text] [Related]

  • 2. Genetic testing in presymptomatic diagnosis of multiple endocrine neoplasia.
    Calender A, Giraud S, Schuffenecker I, Lenoir GM, Gaudray P, Courseaux A, Porchet N, Aubert JP, Zhang CX.
    Horm Res; 1997 Jun; 47(4-6):199-210. PubMed ID: 9167953
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clinical genetics of multiple endocrine neoplasias, Carney complex and related syndromes.
    Stratakis CA.
    J Endocrinol Invest; 2001 May; 24(5):370-83. PubMed ID: 11407658
    [Abstract] [Full Text] [Related]

  • 7. Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis.
    Hansford JR, Mulligan LM.
    J Med Genet; 2000 Nov; 37(11):817-27. PubMed ID: 11073534
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Multiple endocrine neoplasia type 1 and 2: from morphology to molecular pathology 1997.
    Komminoth P.
    Verh Dtsch Ges Pathol; 1997 Nov; 81():125-38. PubMed ID: 9474863
    [Abstract] [Full Text] [Related]

  • 10. Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours.
    Eng C, Smith DP, Mulligan LM, Nagai MA, Healey CS, Ponder MA, Gardner E, Scheumann GF, Jackson CE, Tunnacliffe A.
    Hum Mol Genet; 1994 Feb; 3(2):237-41. PubMed ID: 7911697
    [Abstract] [Full Text] [Related]

  • 11. [The molecular genetics of multiple endocrine neoplasia type 2A and 2B].
    Yoshimoto K.
    Nihon Rinsho; 1994 Apr; 52(4):1081-6. PubMed ID: 7910861
    [Abstract] [Full Text] [Related]

  • 12. [Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers].
    Sansó G, Domené HM, Iorcansky S, Barontini M.
    Medicina (B Aires); 1998 Apr; 58(2):179-84. PubMed ID: 9706252
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B.
    Carlson KM, Dou S, Chi D, Scavarda N, Toshima K, Jackson CE, Wells SA, Goodfellow PJ, Donis-Keller H.
    Proc Natl Acad Sci U S A; 1994 Feb 15; 91(4):1579-83. PubMed ID: 7906417
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC.
    Donis-Keller H, Dou S, Chi D, Carlson KM, Toshima K, Lairmore TC, Howe JR, Moley JF, Goodfellow P, Wells SA.
    Hum Mol Genet; 1993 Jul 15; 2(7):851-6. PubMed ID: 8103403
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.